Santaris Pharma A/S

CUREON

Diagnostic preparations for medical purposes, excluding diagnostic preparations for gastro-intestinal disorders; pharmaceutical and veterinary preparations for the treatment of infectious diseases, metabolic disorders and oncological disorders, excluding gastro-intestinal disorders; vaccines, excluding vaccines for gastro-intestinal disorders;Chemicals for use in industry and science; diagnostic reagents for clinical or medical laboratory use, excluding medical diagnostic reagents for gastro-intestinal disorders; reagents for scientific or medical research use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating infectious diseases, metabolic disorders and oncological disorders, excluding gastro-intestinal disorders; chemicals for use in the manufacture of medical and scientific diagnostic preparations, excluding use in the manufacture of medical and scientific diagnostic preparations for gastro-intestinal disorders; nucleotides, oligonucleotides and oligonucleotide analogues for medical research and scientific use, excluding medical research and scientific use for gastro-intestinal disorders;The wording CUREON has no meaning in a foreign language.;research and development of pharmaceuticals, excluding pharmaceuticals for gastro-intestinal disorders; scientific analysis in the field of industrial pharmaceutical development, excluding pharmaceuticals for gastro-intestinal disorders; biological research, excluding biological research for gastro-intestinal disorders; chemical research, excluding chemical research for gastro-intestinal disorders;

LNA-ANTIMIR

Pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases;LNA-ANTIMI R;Chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development;Scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products;

SANTARIS PHARMA A/S

Pharmaceutical and veterinary preparations, namely, preparations comprising nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs for treating of diseases, disorders and afflictions except for preparations directed to gastrointestinal diseases and disorders;PHARMA A/S;Scientific and technological services, namely, research and design in the field of nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs except for preparations directed to gastrointestinal diseases and disorders; development of medical and biomedical products and preparations, namely, in the field of nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs except for preparations directed to gastrointestinal diseases and disorders; biomedical and biotechnological analysis of RNA expression and protein expression, and biomedical and biotechnological research; biochemical and molecular biological analysis of RNA expression and protein expression; scientific, biotechnological and biomedical consultancy, namely, in the field of disease related RNA expression and protein expression; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical and veterinary preparations, methods and products except for preparations directed to gastrointestinal diseases and disorders; analysis of therapeutic effects of chemical, pharmaceutical, medical and veterinary preparations, namely, analysis in the field of medicine and veterinary medicine except for preparations directed to gastrointestinal diseases and disorders;